Public Summary Documents from the March 2014 PBAC meeting

The links to the Public Summary Documents (PSDs) from the March 2014 PBAC meeting have been added to MAESTrO Australia PBAC. ...

Read more →

New drug deal will sweeten PBS fix

The government will bank $3.7 billion in savings from its reforms to the Pharmaceutical Benefits Scheme, arguing that the drive ...

Read more →

Relevant additions and changes from the 1 May 2014 issue of the Schedule of Pharmaceutical Benefits have been added to MAESTrO Australia

[:content [\1 \space \M \a \y \space \2 \0 \1 \4 \space \- \space \T \h \e \space \f \o \l \l \o \w \i \n \g \space \a \d \d \i \t \i \o \n \s \space \a \n \d \space \c \h \a \n \g \e \s \space \h \a \v \e \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \M \A \E \S \T \r \O \space \A \u \s \t \r \a \l \i \a \: " ..."]]
Read more →

Statement by the PBAC - safety of biosimilar medicines

The Pharmaceutical Benefits Advisory Committee (PBAC) has released a statement on the safety of biosimilar medicines. ...

Read more →

Indicative 1 October 2015 PBS prices - 2015 October cycle

Indicative 1 October 2015 prices resulting from the 2015 October Cycle of Price Disclosure have now been published on the Price ...

Read more →

Poll finds backing for cancer drug subsidies

A poll conducted as part of a campaign to improve access to cancer drugs has found more support for subsidised ...

Read more →

NICE draft guidance recommend the use of ribavirin with peginterferon to treat chronic children and young people with hepatitis C virus infection

[:content [\T \h \e \space \N \I \C \E \  \A \p \p \r \a \i \s \a \l \space \C \o \m \m \i \t \t \e \e \space \h \a \s \space \c \o \n \c \l \u \d \e \d \space \t \h \a \t \space \t \r \e \a \t \m \e \n \t \space \w \i \t \h \space \r \i \b \a \v \i \r \i \n \space \a \n \d \  \p \e \g \i \n \t \e \r \f \e \r \o \n \space \a \l \f \a \space \c \a \n \space \d \e \c \r \e \a \s \e \space \t \h \e \space \h \e \p \a \t \i \t \i \s \space \C \space \v \i \r \u \s \space \t \o \space \u \n \d \e \t \e \c \t \a \b \l \e \space \l \e \v \e \l \s \, " ..."]]
Read more →

Stakeholder forum outcomes - asthma post-market review

[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \  " ..."]]
Read more →

2014 Budget information on the Pharmaceutical Benefits Scheme

Why are these changes being made? ...

Read more →

Post-market review of the Life Saving Drugs Programme

The Life Saving Drugs Programme (LSDP) submission process closed on Monday 10 November 2014. The public submissions are now available ...

Read more →

Budget 2015: Federal Government to subsidise $1.3 billion life-saving drugs

Patients waiting on life saving medicines will get a sweetener in this week's budget with the Federal Government spending $1.3 ...

Read more →

TPP 'no threat to medicine'

11 December 3013 - Trade Minister Andrew Robb has hit back at warnings that a mammoth regional trade deal could push ...
Read more →

Big pharma shuffles the tax pill

The big miners were sprung for their Singapore profits sling, and the United States tech giants shown up for their Byzantine tax structures, ...

Read more →

Schedule of Pharmaceutical Benefits - 1 August 2015 update

The August 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The Schedule inclides the ...

Read more →

Generic medicine prices to drop by up to $1 under budget savings measure that helps consumers

Prescription medicine copayments will be cut by between 50 cents and $1 under a federal budget plan that could save taxpayers ...

Read more →